13C-Methacetin

13C-美沙西丁

Report date: 2025/12/11 17:56:16
NME

Base Information

Drug Name13C-Methacetin
Drug Alias Namemethoxy-13C碳[13C]美沙西汀13C-美沙西丁甲氧基-13c碳-13美沙西汀 +[8] 
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver CirrhosisLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Richen-Bases Bio & Sci Co LtdBeijing Richen-Force Science & Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A